These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
514 related items for PubMed ID: 25861974
1. Comparison of the prognosis of bisphosphonate-related osteonecrosis of the jaw caused by oral and intravenous bisphosphonates. Shintani T, Hayashido Y, Mukasa H, Akagi E, Hoshino M, Ishida Y, Hamana T, Okamoto K, Kanda T, Koizumi K, Yoshioka Y, Tani R, Toratani S, Okamoto T. Int J Oral Maxillofac Surg; 2015 Jul; 44(7):840-4. PubMed ID: 25861974 [Abstract] [Full Text] [Related]
3. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital. Taylor T, Bryant C, Popat S. Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162 [Abstract] [Full Text] [Related]
8. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws. Dodson TB. J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814 [Abstract] [Full Text] [Related]
9. [Encounter of cancer cells with bone. Present status and problems in occurrence of bisphosphonate-related osteonecrosis of the jaws]. Urade M. Clin Calcium; 2011 Mar; 21(3):420-7. PubMed ID: 21358064 [Abstract] [Full Text] [Related]
10. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review. Vescovi P, Nammour S. Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666 [Abstract] [Full Text] [Related]
11. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study. Otto S, Abu-Id MH, Fedele S, Warnke PH, Becker ST, Kolk A, Mücke T, Mast G, Köhnke R, Volkmer E, Haasters F, Lieger O, Iizuka T, Porter S, Campisi G, Colella G, Ploder O, Neff A, Wiltfang J, Ehrenfeld M, Kreusch T, Wolff KD, Stürzenbaum SR, Schieker M, Pautke C. J Craniomaxillofac Surg; 2011 Jun; 39(4):272-7. PubMed ID: 20580566 [Abstract] [Full Text] [Related]
15. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Madrid C, Sanz M. Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954 [Abstract] [Full Text] [Related]
17. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? Otto S, Tröltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C. J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767 [Abstract] [Full Text] [Related]
18. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw. Chu V, American Association of Oral and Maxillofacial Surgeons, American Dental Association. Hawaii Dent J; 2008 Jul; 39(5):9-12; quiz 17. PubMed ID: 19189512 [Abstract] [Full Text] [Related]
19. Multipotent mesenchymal stromal cell sheet therapy for bisphosphonate-related osteonecrosis of the jaw in a rat model. Kaibuchi N, Iwata T, Yamato M, Okano T, Ando T. Acta Biomater; 2016 Sep 15; 42():400-410. PubMed ID: 27326918 [Abstract] [Full Text] [Related]
20. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate. Ulmner M, Jarnbring F, Törring O. J Oral Maxillofac Surg; 2014 Jan 15; 72(1):76-82. PubMed ID: 23992777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]